Renal fibrosis in feline chronic kidney disease: Known mediators and mechanisms of injury

Veterinary Journal

Volumn 203, Issue 1, 2015, Pages 18-26

  Lawson, Jack ^a   Elliott, Jonathan ^a   Wheeler Jones, Caroline ^a   Syme, Harriet ^a   Jepson, Rosanne ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Ageing; CKD; Phosphate; Proteinuria; TGF beta

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN 1; PHOSPHATE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; RENIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

AGING; BIOACCUMULATION; CAT; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; EXTRACELLULAR MATRIX; HYPERPHOSPHATEMIA; HYPOXIA; KIDNEY FIBROSIS; KIDNEY INJURY; NONHUMAN; PROTEIN EXPRESSION; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; ANIMAL; CAT DISEASE; CHRONIC KIDNEY FAILURE; ENZYMOLOGY; GENE EXPRESSION REGULATION; KIDNEY; PATHOLOGY; PHYSIOLOGY; VETERINARY;

FELIDAE;

ANIMALS; CAT DISEASES; CATS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; KIDNEY; RENAL INSUFFICIENCY, CHRONIC; RENIN-ANGIOTENSIN SYSTEM;

EID: 84921628481     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2014.10.009     Document Type: Review

References (155)

1. Abbate M., Zoja C., Corna D., Capitanio M., Bertani T., Remuzzi G. In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation. Journal of the American Society of Nephrology 1998, 9:1213-1224.
2. Abbate M., Zoja C., Rottoli D., Corna D., Tomasoni S., Remuzzi G. Proximal tubular cells promote fibrogenesis by TGF-beta1-mediated induction of peritubular myofibroblasts. Kidney International 2002, 61:2066-2077.
3. Abrass C.K., Adcox M.J., Raugi G.J. Aging-associated changes in renal extracellular matrix. The American Journal of Pathology 1995, 146:742-752.
4. Annes J.P., Munger J.S., Rifkin D.B. Making sense of latent TGFbeta activation. Journal of Cell Science 2003, 116:217-224.
5. Arata S., Ohmi A., Mizukoshi F., Baba K., Ohno K., Setoguchi A., Tsujimoto H. Urinary transforming growth factor-beta1 in feline chronic renal failure. The Journal of Veterinary Medical Science 2005, 67:1253-1255.
6. Atlas S.A. The renin-angiotensin aldosterone system: Pathophysiological role and pharmacologic inhibition. Journal of Managed Care Pharmacy 2007, 13:9-20.
7. Bartlett P.C., Van Buren J.W., Neterer M., Zhou C. Disease surveillance and referral bias in the veterinary medical database. Preventive Veterinary Medicine 2010, 94:264-271.
8. Beck G.R., Zerler B., Moran E. Phosphate is a specific signal for induction of osteopontin gene expression. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:8352-8357.
9. Belkin A.M. Extracellular TG2: Emerging functions and regulation. The FEBS Journal 2011, 278:4704-4716.
10. Benigni A., Zoja C., Corna D., Orisio S., Longaretti L., Bertani T., Remuzzi G. A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney International 1993, 44:440-444.
11. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science 1998, 279:349-352.
12. Bonventre J.V. Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. Journal of the American Society of Nephrology 2003, 14(Suppl. 1):S55-S61.
13. Border W.A., Noble N.A. Cytokines in kidney disease: The role of transforming growth factor-beta. American Journal of Kidney Diseases 1993, 22:105-113.
14. Braun H., Schmidt B.M.W., Raiss M., Baisantry A., Mircea-Constantin D., Wang S.J., Gross M.L., Serrano M., Schmitt R., Melk A. Cellular senescence limits regenerative capacity and allograft survival. Journal of the American Society of Nephrology 2012, 23:1467-1473.
15. Camalier C.E., Yi M., Yu L.R., Hood B.L., Conrads K.A., Lee Y.J., Lin Y., Garneys L.M., Bouloux G.F., Young M.R., et al. An integrated understanding of the physiological response to elevated extracellular phosphate. Journal of Cellular Physiology 2013, 228:1536-1550.
16. Chakrabarti S. Mechanisms of Fibrosis in Feline Chronic Kidney Disease 2012, Royal Veterinary College, London.
17. Chakrabarti S., Syme H.M., Elliott J. Clinicopathological variables predicting progression of azotemia in cats with chronic kidney disease. Journal of Veterinary Internal Medicine 2012, 26:275-281.
18. Chakrabarti S., Syme H.M., Elliott J. Urinary vascular endothelial growth factor as a prognostic marker in feline chronic kidney disease. Journal of Veterinary Internal Medicine 2012, 26:1524.
19. Chakrabarti S., Syme H.M., Brown C.A., Elliott J. Histomorphometry of feline chronic kidney disease and correlation with markers of renal dysfunction. Veterinary Pathology 2013, 50:147-155.
20. Chen Z., Chen D., McCarthy T.L., Centrella M., Zhang Y., Moeckel G.W. Inorganic phosphate stimulates fibronectin expression in renal fibroblasts. Cellular Physiology and Biochemistry 2012, 30:151-159.
21. Choi Y.J., Chakraborty S., Nguyen V., Nguyen C., Kim B.K., Shim S.I., Suki W.N., Truong L.D. Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: Altered expression of vascular endothelial growth factor. Human Pathology 2000, 31:1491-1497.
22. Chou J.S., Reiser I.W., Porush J.G. Aging and urinary excretion of epidermal growth factor. Annals of Clinical and Laboratory Science 1997, 27:116-122.
23. Cozzolino M., Dusso A.S., Liapis H., Finch J., Lu Y., Burke S.K., Slatopolsky E. The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats. Journal of the American Society of Nephrology 2002, 13:2299-2308.
24. Craig J.M. Observations on the kidney after phosphate loading in the rat. Archives of Pathology 1959, 68:306-315.
25. Di Marco G.S., Hausberg M., Hillebrand U., Rustemeyer P., Wittkowski W., Lang D., Pavenstadt H. Increased inorganic phosphate induces human endothelial cell apoptosis in vitro. American Journal of Physiology - Renal Physiology 2008, 294:F1381-F1387.
26. DiBartola S.P., Rutgers H.C., Zack P.M., Tarr M.J. Clinicopathologic findings associated with chronic renal disease in cats: 74 cases (1973-1984). Journal of the American Veterinary Medical Association 1987, 190:1196-1202.
27. Ding G., Franki N., Kapasi A.A., Reddy K., Gibbons N., Singhal P.C. Tubular cell senescence and expression of TGF-beta1 and p21(WAF1/CIP1) in tubulointerstitial fibrosis of aging rats. Experimental and Molecular Pathology 2001, 70:43-53.
28. Duan S.B., Liu F.Y., Luo J.A., Peng Y.M. Assessment of urinary endothelin-1 and nitric oxide levels and their relationship with clinical and pathologic types in primary glomerulonephritis. Yonsei Medical Journal 1999, 40:425-429.
29. Ebihara I., Nakamura T., Tomino Y., Koide H. Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis. Nephrology, Dialysis, Transplantation 1997, 12:1001-1006.
30. Eddy A.A. Molecular insights into renal interstitial fibrosis. Journal of the American Society of Nephrology 1996, 7:2495-2508.
31. Eddy A.A., Giachelli C.M. Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney International 1995, 47:1546-1557.
32. Edwards D.R., Murphy G., Reynolds J.J., Whitham S.E., Docherty A.J., Angel P., Heath J.K. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. The EMBO Journal 1987, 6:1899-1904.
33. Epstein F.H. Oxygen and renal metabolism. Kidney International 1997, 51:381-385.
34. Eraranta A., Riutta A., Fan M., Koskela J., Tikkanen I., Lakkisto P., Niemela O., Parkkinen J., Mustonen J., Porsti I. Dietary phosphate binding and loading alter kidney angiotensin-converting enzyme mRNA and protein content in 5/6 nephrectomized rats. American Journal of Nephrology 2012, 35:401-408.
35. Evans R.G., Gardiner B.S., Smith D.W., O'Connor P.M. Intrarenal oxygenation: Unique challenges and the biophysical basis of homeostasis. American Journal of Physiology - Renal Physiology 2008, 295:F1259-F1270.
36. Farris A.B., Colvin R.B. Renal interstitial fibrosis: Mechanisms and evaluation. Current Opinion in Nephrology and Hypertension 2012, 21:289-300.
37. Finco D.R., Brown S.A., Crowell W.A., Duncan R.J., Barsanti J.A., Bennett S.E. Effects of dietary phosphorus and protein in dogs with chronic renal failure. American Journal of Veterinary Research 1992, 53:2264-2271.
38. Fukuda K., Yoshitomi K., Yanagida T., Tokumoto M., Hirakata H. Quantification of TGF-beta1 mRNA along rat nephron in obstructive nephropathy. American Journal of Physiology - Renal Physiology 2001, 281:F513-F521.
39. Garber S.L., Mirochnik Y., Desai S.S., Arruda J.A., Dunea G. Angiotensin-converting enzyme inhibition reduces the effect of bromoethylamine-induced papillary necrosis and renal fibrosis. Journal of the American Society of Nephrology 1998, 9:1052-1059.
40. Gentle M.E., Shi S., Daehn I., Zhang T., Qi H., Yu L., D'Agati V.D., Schlondorff D.O., Bottinger E.P. Epithelial cell TGFbeta signaling induces acute tubular injury and interstitial inflammation. Journal of the American Society of Nephrology 2013, 24:787-799.
41. Gimenez L.F., Solez K., Walker W.G. Relation between renal calcium content and renal impairment in 246 human renal biopsies. Kidney International 1987, 31:93-99.
42. Grotendorst G.R. Connective tissue growth factor: A mediator of TGF-beta action on fibroblasts. Cytokine and Growth Factor Reviews 1997, 8:171-179.
43. Habenicht L.M., Webb T.L., Clauss L.A., Dow S.W., Quimby J.M. Urinary cytokine levels in apparently healthy cats and cats with chronic kidney disease. Journal of Feline Medicine and Surgery 2013, 15:99-104.
44. Han K.H., Kang Y.S., Han S.Y., Jee Y.H., Lee M.H., Han J.Y., Kim H.K., Kim Y.S., Cha D.R. Spironolactone ameliorates renal injury and connective tissue growth factor expression in type II diabetic rats. Kidney International 2006, 70:111-120.
45. Harris D.C., Chan L., Schrier R.W. Remnant kidney hypermetabolism and progression of chronic renal failure. The American Journal of Physiology 1988, 254:F267-F276.
46. Haut L.L., Alfrey A.C., Guggenheim S., Buddington B., Schrier N. Renal toxicity of phosphate in rats. Kidney International 1980, 17:722-731.
47. He J., Xu Y., Koya D., Kanasaki K. Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease. Clinical and Experimental Nephrology 2013, 17:488-497.
48. Hocher B., Thone-Reineke C., Rohmeiss P., Schmager F., Slowinski T., Burst V., Siegmund F., Quertermous T., Bauer C., Neumayer H.H., et al. Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. The Journal of Clinical Investigation 1997, 99:1380-1389.
49. Hostetter T.H., Olson J.L., Rennke H.G., Venkatachalam M.A., Brenner B.M. Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. The American Journal of Physiology 1981, 241:F85-F93.
50. Huang L., Haylor J.L., Hau Z., Jones R.A., Vickers M.E., Wagner B., Griffin M., Saint R.E., Coutts I.G., El Nahas A.M., et al. Transglutaminase inhibition ameliorates experimental diabetic nephropathy. Kidney International 2009, 76:383-394.
51. Huang Y., Wongamorntham S., Kasting J., McQuillan D., Owens R.T., Yu L., Noble N.A., Border W. Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney International 2006, 69:105-113.
52. Hughes A.K., Stricklett P.K., Padilla E., Kohan D.E. Effect of reactive oxygen species on endothelin-1 production by human mesangial cells. Kidney International 1996, 49:181-189.
53. Hughes K.L., Slater M.R., Geller S., Burkholder W.J., Fitzgerald C. Diet and lifestyle variables as risk factors for chronic renal failure in pet cats. Preventive Veterinary Medicine 2002, 55:1-15.
54. Iismaa S.E., Mearns B.M., Lorand L., Graham R.M. Transglutaminases and disease: Lessons from genetically engineered mouse models and inherited disorders. Physiological Reviews 2009, 89:991-1023.
55. Ishidoya S., Morrissey J., McCracken R., Klahr S. Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney International 1996, 49:1110-1119.
56. Jabs A., Moncada G.A., Nichols C.E., Waller E.K., Wilcox J.N. Peripheral blood mononuclear cells acquire myofibroblast characteristics in granulation tissue. Journal of Vascular Research 2005, 42:174-180.
57. Jepson R.E., Brodbelt D., Vallance C., Syme H.M., Elliott J. Evaluation of predictors of the development of azotemia in cats. Journal of Veterinary Internal Medicine 2009, 23:806-813.
58. Johnson T.S. Tissue transglutaminase and the progression of human renal scarring. Journal of the American Society of Nephrology 2003, 14:2052-2062.
59. Johnson T.S., Skill N.J., El Nahas A.M., Oldroyd S.D., Thomas G.L., Douthwaite J.A., Haylor J.L., Griffin M. Transglutaminase transcription and antigen translocation in experimental renal scarring. Journal of the American Society of Nephrology 1999, 10:2146-2157.
60. Johnson T.S., Fisher M., Haylor J.L., Hau Z., Skill N.J., Jones R., Saint R., Coutts I., Vickers M.E., El Nahas A.M., et al. Transglutaminase inhibition reduces fibrosis and preserves function in experimental chronic kidney disease. Journal of the American Society of Nephrology 2007, 18:3078-3088.
61. Juknevicius I., Segal Y., Kren S., Lee R., Hostetter T.H. Effect of aldosterone on renal transforming growth factor-beta. American Journal of Physiology - Renal Physiology 2004, 286:F1059-F1062.
62. Kang D.H., Kanellis J., Hugo C., Truong L., Anderson S., Kerjaschki D., Schreiner G.F., Johnson R.J. Role of the microvascular endothelium in progressive renal disease. Journal of the American Society of Nephrology 2002, 13:806-816.
63. Kendrick J., Chonchol M. The role of phosphorus in the development and progression of vascular calcification. American Journal of Kidney Diseases 2011, 58:826-834.
64. Khan S., Cleveland R.P., Koch C.J., Schelling J.R. Hypoxia induces renal tubular epithelial cell apoptosis in chronic renal disease. Laboratory Investigation 1999, 79:1089-1099.
65. Kim D.S., Kim B., Tahk H., Kim D.H., Ahn E.R., Choi C., Jeon Y., Park S.Y., Lee H., Oh S.H., et al. Transglutaminase 2 gene ablation protects against renal ischemic injury by blocking constant NF-kappaB activation. Biochemical and Biophysical Research Communications 2010, 403:479-484.
66. Kim M.K., Maeng Y.I., Sung W.J., Oh H.K., Park J.B., Yoon G.S., Cho C.H., Park K.K. The differential expression of TGF-beta1, ILK and wnt signaling inducing epithelial to mesenchymal transition in human renal fibrogenesis: An immunohistochemical study. International Journal of Clinical and Experimental Pathology 2013, 6:1747-1758.
67. King J.N., Gunn-Moore D.A., Tasker S., Gleadhill A., Strehlau G. Tolerability and efficacy of benazepril in cats with chronic kidney disease. Journal of Veterinary Internal Medicine 2006, 20:1054-1064. Benazepril in Renal Insufficiency in Cats Study Group.
68. Ko G.J., Boo C.S., Jo S.K., Cho W.Y., Kim H.K. Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusion-induced acute kidney injury. Nephrology, Dialysis, Transplantation 2008, 23:842-852.
69. Kobori H., Nangaku M., Navar L.G., Nishiyama A. The intrarenal renin-angiotensin system: From physiology to the pathobiology of hypertension and kidney disease. Pharmacological Reviews 2007, 59:251-287.
70. Koesters R., Kaissling B., Lehir M., Picard N., Theilig F., Gebhardt R., Glick A.B., Hahnel B., Hosser H., Grone H.J., et al. Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. The American Journal of Pathology 2010, 177:632-643.
71. Kohno M., Horio T., Ikeda M., Yokokawa K., Fukui T., Yasunari K., Kurihara N., Takeda T. Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells. Kidney International 1992, 42:860-866.
72. Koizumi T., Murakami K., Nakayama H., Kuwahara T., Yoshinari O. Role of dietary phosphorus in the progression of renal failure. Biochemical and Biophysical Research Communications 2002, 295:917-921.
73. Kong T., Eltzschig H.K., Karhausen J., Colgan S.P., Shelley C.S. Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of beta2 integrin gene expression. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:10440-10445.
74. Krag S., Danielsen C.C., Carmeliet P., Nyengaard J., Wogensen L. Plasminogen activator inhibitor-1 gene deficiency attenuates TGF-beta1-induced kidney disease. Kidney International 2005, 68:2651-2666.
75. Kuro-o M. A potential link between phosphate and aging - Lessons from Klotho-deficient mice. Mechanisms of Ageing and Development 2010, 131:270-275.
76. Laouari D., Kleinknecht C., Cournot-Witmer G., Habib R., Mounier F., Broyer M. Beneficial effect of low phosphorus diet in uraemic rats: A reappraisal. Clinical Science 1982, 63:539-548.
77. Lappin M.R., Basaraba R.J., Jensen W.A. Interstitial nephritis in cats inoculated with Crandell Rees feline kidney cell lysates. Journal of Feline Medicine and Surgery 2006, 8:353-356.
78. Largo R., Gomez-Garre D., Soto K., Marron B., Blanco J., Gazapo R.M., Plaza J.J., Egido J. Angiotensin-converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria. Hypertension 1999, 33:732-739.
79. Lawler D.F., Evans R.H., Chase K., Ellersieck M., Li Q., Larson B.T., Satyaraj E., Heininger K. The aging feline kidney: A model mortality antagonist?. Journal of Feline Medicine and Surgery 2006, 8:363-371.
80. Lebel M., Rodrigue M.E., Agharazii M., Lariviere R. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin. American Journal of Hypertension 2006, 19:1286-1292.
81. Lebleu V.S., Taduri G., O'Connell J., Teng Y., Cooke V.G., Woda C., Sugimoto H., Kalluri R. Origin and function of myofibroblasts in kidney fibrosis. Nature Medicine 2013, 19:1047-1053.
82. Lee S., Huen S., Nishio H., Nishio S., Lee H.K., Choi B.S., Ruhrberg C., Cantley L.G. Distinct macrophage phenotypes contribute to kidney injury and repair. Journal of the American Society of Nephrology 2011, 22:317-326.
83. Liu Y. Renal fibrosis: New insights into the pathogenesis and therapeutics. Kidney International 2006, 69:213-217.
84. Lulich J.P., Osborne C.A., O'Brien T.D., Polzin D.J. Feline renal failure: Questions, answers, questions. Compendium on Continuing Education for the Practising Veterinarian 1992, 14:127-152.
85. Lumlertgul D., Burke T.J., Gillum D.M., Alfrey A.C., Harris D.C., Hammond W.S., Schrier R.W. Phosphate depletion arrests progression of chronic renal failure independent of protein intake. Kidney International 1986, 29:658-666.
86. Mackay E.M., Oliver J. Renal damage following the ingestion of a diet containing an excess of inorganic phosphate. The Journal of Experimental Medicine 1935, 61:319-334.
87. Manotham K., Tanaka T., Matsumoto M., Ohse T., Miyata T., Inagi R., Kurokawa K., Fujita T., Nangaku M. Evidence of tubular hypoxia in the early phase in the remnant kidney model. Journal of the American Society of Nephrology 2004, 15:1277-1288.
88. Maschio G., Alberti D., Janin G., Locatelli F., Mann J.F., Motolese M., Ponticelli C., Ritz E., Zucchelli P. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. The New England Journal of Medicine 1996, 334:939-945.
89. Melk A., Schmidt B.M.W., Braun H., Vongwiwatana A., Urmson J., Zhu L.F., Rayner D., Halloran P.F. Effects of donor age and cell senescence on kidney allograft survival. American Journal of Transplantation 2009, 9:114-123.
90. Mimura I., Nangaku M. The suffocating kidney: Tubulointerstitial hypoxia in end-stage renal disease. Nature Reviews. Nephrology 2010, 6:667-678.
91. Minkus G., Reusch C., Hörauf A., Breuer W., Darbès J., Kraft W., Hermanns W. Evaluation of renal biopsies in cats and dogs - Histopathology in comparison with clinical data. Journal of Small Animal Practice 1994, 35:465-472.
92. Mitani S., Yabuki A., Taniguchi K., Yamato O. Association between the intrarenal renin-angiotensin system and renal injury in chronic kidney disease of dogs and cats. The Journal of Veterinary Medical Science 2013, 75:127-133.
93. Mizuno S., Horikawa Y., Okamoto M., Kurosawa T. Preventive effect of ACE inhibitor on interstitial myofibroblast formation and matrix deposition in a nephrotic model. Renal Failure 1998, 20:481-491.
94. Mizutani H., Koyama H., Watanabe T., Kitagawa H., Nakano M., Kajiwara K., King J.N. Evaluation of the clinical efficacy of benazepril in the treatment of chronic renal insufficiency in cats. Journal of Veterinary Internal Medicine 2006, 20:1074-1079.
95. Moll S., Ebeling M., Weibel F., Farina A., Araujo Del Rosario A., Hoflack J.C., Pomposiello S., Prunotto M. Epithelial cells as active player in fibrosis: Findings from an in vitro model. PLoS ONE 2013, 8:e56575.
96. Nakajima H., Takenaka M., Kaimori J.Y., Nagasawa Y., Kosugi A., Kawamoto S., Imai E., Hori M., Okubo K. Gene expression profile of renal proximal tubules regulated by proteinuria. Kidney International 2002, 61:1577-1587.
97. Nakamura T., Ushiyama C., Shimada N., Hayashi K., Ebihara I., Koide H. Comparative effects of pioglitazone, glibenclamide, and voglibose on urinary endothelin-1 and albumin excretion in diabetes patients. Journal of Diabetes and Its Complications 2000, 14:250-254.
98. Nangaku M., Fujita T. Activation of the renin-angiotensin system and chronic hypoxia of the kidney. Hypertension Research 2008, 31:175-184.
99. Nath K.A. Tubulointerstitial changes as a major determinant in the progression of renal damage. American Journal of Kidney Diseases 1992, 20:1-17.
100. Nikolic-Paterson D.J. CD4+ T cells: A potential player in renal fibrosis. Kidney International 2010, 78:333-335.
101. Norman J.T., Clark I.M., Garcia P.L. Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney International 2000, 58:2351-2366.
102. Ohnishi M., Razzaque M.S. Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging. FASEB Journal 2010, 24:3562-3571.
103. Ong A.C., Newby L.J., Dashwood M.R. Expression and cellular localisation of renal endothelin-1 and endothelin receptor subtypes in autosomal-dominant polycystic kidney disease. Nephron. Experimental Nephrology 2003, 93:e80.
104. Orphanides C., Fine L.G., Norman J.T. Hypoxia stimulates proximal tubular cell matrix production via a TGF-beta1-independent mechanism. Kidney International 1997, 52:637-647.
105. Pannarale G., Carbone R., Del Mastro G., Gallo C., Gattullo V., Natalicchio L., Navarra A., Tedesco A. The aging kidney: Structural changes. Journal of Nephrology 2010, 23(Suppl. 15):S37-S40.
106. Prunotto M., Ghiggeri G., Bruschi M., Gabbiani G., Lescuyer P., Hocher B., Chaykovska L., Berrera M., Moll S. Renal fibrosis and proteomics: Current knowledge and still key open questions for proteomic investigation. Journal of Proteomics 2011, 74:1855-1870.
107. Prunotto M., Budd D.C., Gabbiani G., Meier M., Formentini I., Hartmann G., Pomposiello S., Moll S. Epithelial-mesenchymal crosstalk alteration in kidney fibrosis. The Journal of Pathology 2012, 228:131-147.
108. Qi W., Chen X., Poronnik P., Pollock C.A. The renal cortical fibroblast in renal tubulointerstitial fibrosis. The International Journal of Biochemistry and Cell Biology 2006, 38:1-5.
109. Quimby J.M., Maranon D.G., Battaglia C.L., McLeland S.M., Brock W.T., Bailey S.M. Feline chronic kidney disease is associated with shortened telomeres and increased cellular senescence. American Journal of Physiology - Renal Physiology 2013, 305:F295-F303.
110. Reynolds B.S., Lefebvre H.P. Feline CKD: Pathophysiology and risk factors - What do we know?. Journal of Feline Medicine and Surgery 2013, 15(Suppl. 1):3-14.
111. Risdon R.A., Sloper J.C., De Wardener H.E. Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet 1968, 2:363-366.
112. Rodriguez-Iturbe B., Garcia Garcia G. The role of tubulointerstitial inflammation in the progression of chronic renal failure. Nephron. Clinical Practice 2010, 116:c81-c88.
113. Rodriguez-Iturbe B., Pons H., Herrera-Acosta J., Johnson R.J. Role of immunocompetent cells in nonimmune renal diseases. Kidney International 2001, 59:1626-1640.
114. Rohatgi R., Flores D. Intratubular hydrodynamic forces influence tubulointerstitial fibrosis in the kidney. Current Opinion in Nephrology and Hypertension 2010, 19:65-71.
115. Romero F., Rodriguez-Iturbe B., Parra G., Gonzalez L., Herrera-Acosta J., Tapia E. Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats. Kidney International 1999, 55:945-955.
116. Ross L.A., Finco D.R., Crowell W.A. Effect of dietary phosphorus restriction on the kidneys of cats with reduced renal mass. American Journal of Veterinary Research 1982, 43:1023-1026.
117. Roubert P., Gillard-Roubert V., Pourmarin L., Cornet S., Guilmard C., Plas P., Pirotzky E., Chabrier P.E., Braquet P. Endothelin receptor subtypes A and B are up-regulated in an experimental model of acute renal failure. Molecular Pharmacology 1994, 45:182-188.
118. Ruster C., Wolf G. Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis. Journal of the American Society of Nephrology 2011, 22:1189-1199.
119. Sánchez-Lara, A.C., Elliott, J., Syme, H.M., Brown, C., Haylor, J.L., 2013. Feline Chronic Kidney Disease is Associated with Upregulation of Transglutaminase, a Cross-Linking Enzyme. In: ECVIM-CA Congress, Liverpool, p. 719.
120. Sato M., Muragaki Y., Saika S., Roberts A.B., Ooshima A. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. The Journal of Clinical Investigation 2003, 112:1486-1494.
121. Sawashima K., Mizuno S., Mizuno-Horikawa Y., Shimada A., Kudo T., Kurosawa T. Expression of alpha-smooth muscle actin and fibronectin in tubulointerstitial lesions of cats with chronic renal failure. American Journal of Veterinary Research 2000, 61:1080-1086.
122. Schmitt R., Marlier A., Cantley L.G. Zag expression during aging suppresses proliferation after kidney injury. Journal of the American Society of Nephrology 2008, 19:2375-2383.
123. Schnermann J.B., Zhu X.L., Shu X., Yang T., Huang Y.G., Kretzler M., Briggs J.P. Regulation of endothelin production and secretion in cultured collecting duct cells by endogenous transforming growth factor-beta. Endocrinology 1996, 137:5000-5008.
124. Serini G., Bochaton-Piallat M.L., Ropraz P., Geinoz A., Borsi L., Zardi L., Gabbiani G. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. The Journal of Cell Biology 1998, 142:873-881.
125. Shin D.M., Jeon J.H., Kim C.W., Cho S.Y., Lee H.J., Jang G.Y., Jeong E.M., Lee D.S., Kang J.H., Melino G., et al. TGFbeta mediates activation of transglutaminase 2 in response to oxidative stress that leads to protein aggregation. The FASEB Journal 2008, 22:2498-2507.
126. Shuto E., Taketani Y., Tanaka R., Harada N., Isshiki M., Sato M., Nashiki K., Amo K., Yamamoto H., Higashi Y., et al. Dietary phosphorus acutely impairs endothelial function. Journal of the American Society of Nephrology 2009, 20:1504-1512.
127. Shweke N., Boulos N., Jouanneau C., Vandermeersch S., Melino G., Dussaule J.C., Chatziantoniou C., Ronco P., Boffa J.J. Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration. The American Journal of Pathology 2008, 173:631-642.
128. Siragy H.M., Carey R.M. Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease. American Journal of Nephrology 2010, 31:541-550.
129. Strutz F., Zeisberg M. Renal fibroblasts and myofibroblasts in chronic kidney disease. Journal of the American Society of Nephrology 2006, 17:2992-2998.
130. Sun Y., Zhang J., Zhang J.Q., Ramires F.J. Local angiotensin II and transforming growth factor-beta1 in renal fibrosis of rats. Hypertension 2000, 35:1078-1084.
131. Syme H.M., Markwell P.J., Pfeiffer D., Elliott J. Survival of cats with naturally occurring chronic renal failure is related to severity of proteinuria. Journal of Veterinary Internal Medicine 2006, 20:528-535.
132. Takemura A., Iijima K., Ota H., Son B.K., Ito Y., Ogawa S., Eto M., Akishita M., Ouchi Y. Sirtuin 1 retards hyperphosphatemia-induced calcification of vascular smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2011, 31:2054-2062.
133. Tamada S., Nakatani T., Asai T., Tashiro K., Komiya T., Sumi T., Okamura M., Kim S., Iwao H., Kishimoto T., et al. Inhibition of nuclear factor-kappaB activation by pyrrolidine dithiocarbamate prevents chronic FK506 nephropathy. Kidney International 2003, 63:306-314.
134. Tapmeier T.T., Fearn A., Brown K., Chowdhury P., Sacks S.H., Sheerin N.S., Wong W. Pivotal role of CD4+ T cells in renal fibrosis following ureteric obstruction. Kidney International 2010, 78:351-362.
135. Taugner F., Baatz G., Nobiling R. The renin-angiotensin system in cats with chronic renal failure. Journal of Comparative Pathology 1996, 115:239-252.
136. Tejera N., Gomez-Garre D., Lazaro A., Gallego-Delgado J., Alonso C., Blanco J., Ortiz A., Egido J. Persistent proteinuria up-regulates angiotensin II type 2 receptor and induces apoptosis in proximal tubular cells. The American Journal of Pathology 2004, 164:1817-1826.
137. Thomas S.E., Anderson S., Gordon K.L., Oyama T.T., Shankland S.J., Johnson R.J. Tubulointerstitial disease in aging: Evidence for underlying peritubular capillary damage, a potential role for renal ischemia. Journal of the American Society of Nephrology 1998, 9:231-242.
138. Toback F.G. Regeneration after acute tubular necrosis. Kidney International 1992, 41:226-246.
139. Turan T., van Harten J.G., de Water R., Tuncay O.L., Kok D.J. Is enalapril adequate for the prevention of renal tissue damage caused by unilateral ureteral obstruction and/or hyperoxaluria?. Urological Research 2003, 31:212-217.
140. Uchide T., Saida K. Primary structure of cat preproendothelin-2 and cat renal mRNA expression of preproendothelin-1 and preproendothelin-2 in naturally occurring renal failure. Experimental Biology and Medicine 2006, 231:997-1000.
141. Vielhauer V., Berning E., Eis V., Kretzler M., Segerer S., Strutz F., Horuk R., Grone H.J., Schlondorff D., Anders H.J. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome. Kidney International 2004, 66:2264-2278.
142. Vlachojannis J.G., Tsakas S., Petropoulou C., Goumenos D.S., Alexandri S. Endothelin-1 in the kidney and urine of patients with glomerular disease and proteinuria. Clinical Nephrology 2002, 58:337-343.
143. Vleming L.J., Baelde J.J., Westendorp R.G., Daha M.R., van Es L.A., Bruijn J.A. Progression of chronic renal disease in humans is associated with the deposition of basement membrane components and decorin in the interstitial extracellular matrix. Clinical Nephrology 1995, 44:211-219.
144. Wang W., Koka V., Lan H.Y. Transforming growth factor-beta and Smad signalling in kidney diseases. Nephrology 2005, 10:48-56.
145. Watanabe T., Mishina M. Effects of benazepril hydrochloride in cats with experimentally induced or spontaneously occurring chronic renal failure. The Journal of Veterinary Medical Science/the Japanese Society of Veterinary Science 2007, 69:1015-1023.
146. Wolf G. Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway. Kidney International 2006, 70:1914-1919.
147. Wolf G., Wenzel U., Burns K.D., Harris R.C., Stahl R.A., Thaiss F. Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors. Kidney International 2002, 61:1986-1995.
148. Wu C.F., Chiang W.C., Lai C.F., Chang F.C., Chen Y.T., Chou Y.H., Wu T.H., Linn G.R., Ling H., Wu K.D., et al. Transforming growth factor beta-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis. The American Journal of Pathology 2013, 182:118-131.
149. Wynn T.A. Fibrosis under arrest. Nature Medicine 2010, 16:523-525.
150. Xie Y., Sakatsume M., Nishi S., Narita I., Arakawa M., Gejyo F. Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney International 2001, 60:1645-1657.
151. Yabuki A., Mitani S., Fujiki M., Misumi K., Endo Y., Miyoshi N., Yamato O. Comparative study of chronic kidney disease in dogs and cats: Induction of myofibroblasts. Research in Veterinary Science 2010, 88:294-299.
152. Yokoi H., Sugawara A., Mukoyama M., Mori K., Makino H., Suganami T., Nagae T., Yahata K., Fujinaga Y., Tanaka I., et al. Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: A potential target for preventing renal fibrosis. American Journal of Kidney Diseases 2001, 38:S134-S138.
153. Zell S., Schmitt R., Witting S., Kreipe H.H., Hussein K., Becker J.U. Hypoxia induces mesenchymal gene expression in renal tubular epithelial cells: An in vitro model of kidney transplant fibrosis. Nephron Extra 2013, 3:50-58.
154. Zoccali C., Ruggenenti P., Perna A., Leonardis D., Tripepi R., Tripepi G., Mallamaci F., Remuzzi G., Group R.S. Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. Journal of the American Society of Nephrology 2011, 22:1923-1930.
155. Zoja C., Benigni A., Remuzzi G. Protein overload activates proximal tubular cells to release vasoactive and inflammatory mediators. Experimental Nephrology 1999, 7:420-428.